A Japanese court ruled that an order for restaurant chain operator Global-Dining Inc. to reduce business hours amid the coronavirus pandemic was illegal, as it did not fulfill certain conditions.
Presiding Judge Norihiro Matsuda stated in his decision that it is difficult to acknowledge that Global-Dining enhanced the chance of the virus spreading throughout the community.
He further claimed that because the directive was issued just days before the state of emergency was removed, it had "just a little influence on infection management."
The metropolitan government claims that Global-Dining's commnets on its website caused other eateries to be hesitant to comply with the decree. The court, however, disagreed.
Global-Dining, on the other hand, claims that imposing blanket limits without providing evidence that restaurants are a source of illnesses is a violation of the Constitutional right of corporate freedom.
The firm, which owns and operates dozens of eateries, promptly filed an appeal.


Federal Judge Orders Restoration of SEVIS Status for Tufts PhD Student Rumeysa Ozturk
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development
Asian Stocks Slide as Central Bank Decisions and Key Data Keep Investors Cautious
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement
Judge Orders Return of Seized Evidence in Comey-Related Case, DOJ May Seek New Warrant
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market
Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
Federal Judge Blocks Trump Administration’s Pause on New Wind-Energy Permits
Supporters Gather Ahead of Verdict in Jimmy Lai’s Landmark Hong Kong National Security Trial 



